Institutional Sign In

Go

Krka - Profitability

ROCE & ROE
Pharmaceutical | Slovenia | April 2, 2020
$2.99
Excel Sheet

Krka made a net profit of EUR 158 mil in 2015, down 4.8% compared to the previous year. Historically, between 2000 and 2015, the company's net profit reached a high of EUR 174 mil in 2009 and a low of EUR 27.6 mil in 2000.

The result implies a return on equity of 11.5% and a return on invested capital of 9.90% in 2015. That is compared to an average of 13.1% and 11.0% over the last five years.

The company has been operating with average EBITDA margin of 27.4% in the last 5 years and an average net margin of 14.2%.

Since 2010, the firm's net profit increased by -7.47% or an average of -1.54% a year.

You can see all the company’s data at Krka profile, or you can download a report on the company in the report section.